Stocktoria

ARS Pharmaceuticals, Inc. SPRY

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-12-04

ARS Pharmaceuticals, Inc. statistics & valuation

Market cap$848.0M
P / S10.1×
P / B7.4×
Net margin-203.3%
Return on equity-149.9%
FCF margin-203.1%
Net debt$55.1M
Enterprise value USD$903.1M
Earnings yield EBIT/EV-19.9%
Return on capital-62.2%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-367.70% -2635.40% -181216.70% 9.00% -203.30% 202020212022202320242025
Gross margin (%)
202020212022202320242025
Operating margin (%)
-353.30% -2698.80% -225066.70% -3.50% -212.90% 202020212022202320242025
Return on equity (%)
-12.70% -23.60% 3.10% -149.90% 202020212022202320242025
Shares outstanding
34.7M 30.4M 93.9M 96.4M 102.4M 99.3M 202020212022202320242025
Net debt ($)
-$50.8M $55.1M 202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-8.30% -32.90% -12.30% -23.30% 2.30% -52.30% 202020212022202320242025
Free cash flow margin (%)
-319.90% -3060.60% -198136.70% 14.60% -203.10% 202020212022202320242025
Debt / equity (×)
0.00× 0.84× 202020212022202320242025
EPS ($)
-$0.70 -$0.87 -$0.57 $0.08 -$1.74 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Operating margin-212.9%-3.5%-225066.7%-2698.8%-353.3%—
Net margin-203.3%9.0%-181216.7%-2635.4%-367.7%—
FCF margin-203.1%14.6%-198136.7%-3060.6%-319.9%—
Return on assets-52.3%2.3%-23.3%-12.3%-32.9%-8.3%
Return on equity-149.9%3.1%-23.6%-12.7%64.7%234.5%
Debt / equity0.84×0.00×————
Current ratio7.2814.2696.9251.017.4240.69

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.